Target intelligence / Profile preview

Serine Beta-Lactamase (Ambler Class C) (None)

Target
None
Molecular classification
Enzyme, Serine hydrolase
01

Overview

Serine beta-lactamases of Ambler class C, commonly referred to as AmpC beta-lactamases or cephalosporinases, are enzymes produced by certain bacteria that confer resistance to a broad range of beta-lactam antibiotics. These enzymes hydrolyze the beta-lactam ring found in these antibiotics, rendering them ineffective against bacterial cell wall synthesis. AmpC enzymes are generally not inhibited by traditional β-lactamase inhibitors such as clavulanic acid or tazobactam. They are significant causes of hospital-acquired infections due to their ability to resist many commonly used β-lactams. Third-generation cephalosporins should generally be avoided when treating infections caused by organisms known for inducible AmpC production, regardless of initial susceptibility test results.

Other names
AmpCcephalosporinase
02

Mechanism of action

Hydrolyzes the beta-lactam ring of antibiotics, rendering them ineffective.

03

Biological functions

Hydrolyzes beta-lactam antibioticsAntibiotic resistance
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Resistance to multiple beta-lactam antibioticsPotential for treatment failure with beta-lactam antibioticsDifficult to inhibit with traditional beta-lactamase inhibitors
06

Interacting drugs

Penicillins

5 more in the full profile.

Beyond the preview

Go deeper on Serine Beta-Lactamase (Ambler Class C) (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine Beta-Lactamase (Ambler Class C) (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call